- Home
- LZB vs QURE Comparison
LZB vs QURE Comparison
Compare LZB & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LZB | QURE |
|---|---|---|
| Founded | 1927 | 1998 |
| Country | United States | Netherlands |
| Employees | N/A | 248 |
| Industry | Home Furnishings | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 663.4M |
| IPO Year | 1994 | 2013 |
Fundamental Metrics
Financial Performance| Metric | LZB | QURE |
|---|---|---|
| Price | $33.24 | $17.69 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 14 |
| Target Price | $42.50 | ★ $45.42 |
| AVG Volume (30 Days) | 368.3K | ★ 4.5M |
| Earning Date | 01-01-0001 | 06-02-2026 |
| Dividend Yield | ★ 2.89% | N/A |
| EPS Growth | N/A | ★ 29.67 |
| EPS | ★ 1.65 | N/A |
| Revenue | ★ $2,349,433,000.00 | $13,107,000.00 |
| Revenue This Year | $1.89 | $126.14 |
| Revenue Next Year | $2.09 | $395.00 |
| P/E Ratio | $20.28 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $29.03 | $7.76 |
| 52 Week High | $44.49 | $71.50 |
Technical Indicators
Market Signals| Indicator | LZB | QURE |
|---|---|---|
| Relative Strength Index (RSI) | 32.25 | 46.92 |
| Support Level | $31.99 | $13.29 |
| Resistance Level | $33.50 | $26.84 |
| Average True Range (ATR) | 0.97 | 2.09 |
| MACD | -0.25 | 0.11 |
| Stochastic Oscillator | 5.96 | 52.73 |
Price Performance
Historical ComparisonAbout LZB La-Z-Boy Incorporated
La-Z-Boy Inc is a U.S.-based company that manufactures, distributes, and retails upholstery furniture products. It is a producer of reclining chairs and distributors of residential furniture in the U.S. The company chiefly operates in the United States but also has secondary operations in Canada and other countries. The company's reportable segments include the Wholesale segment, which manufactures and imports upholstered furniture; Retail, which sells upholstered and case goods furniture to the end consumer and corporate and others. The majority of the company's revenue is derived from its Wholesale segment.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.